ICMR: Hydroxychloroquine could have side-effects

NEW DELHI: Healthcare workers who took anti-malaria drug hydroxychloroquine (HCQ) suffered from its side-effects like abdominal pain, nausea and hypoglycemia according to a study conducted by the Indian Council of Medical Research (ICMR).

ICMR head of epidemiology and communicable diseases, Dr R R Gangakhedkar said that “A study has been launched to know the side-effects of HCQ. We found that healthcare workers having an average age of 35 years took these drugs and 10% reported abdominal pain, 6% reported nausea and 1.3% reported hypoglycemia.”
“Around 22% of these healthcare workers also had other conditions like diabetes, cardiovascular diseases and blood pressure and therefore, probably out of fear, took HCQ as a preventive measure”, he further added.
“We are not doing a trial and we don’t have sufficient evidence base to do a trial. There will be about 480 patients who will be enrolled and it will go on for about 2.5 months,” Dr Gangakhedkar said.

ICMR is also researching to find out the other effects of HCQs.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?